UTRS Stock Chart & Stats
$0.01
$0.00(0.00%)
At close: 4:00 PM EST
$0.01
$0.00(0.00%)
Day’s Range― - ―
52-Week Range$0.01 - $0.01
Previous CloseN/A
Volume1.00
Average Volume (3M)0.00
Market Cap
$9.00
Enterprise Value$32.75M
Total Cash (Recent Filing)$11.13M
Total Debt (Recent Filing)$43.55M
Price to Earnings (P/E)―
Beta85.65
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding8,878,582
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)0.37
Price to Sales (P/S)0.13
P/FCF Ratio-0.18
Enterprise Value/Market Cap3.64M
Enterprise Value/Revenue0.63
Enterprise Value/Gross Profit1.17
Enterprise Value/Ebitda-1.44
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Minerva Surgical News
UTRS FAQ
What was Minerva Surgical’s price range in the past 12 months?
Minerva Surgical lowest stock price was $0.01 and its highest was $0.01 in the past 12 months.
What is Minerva Surgical’s market cap?
Minerva Surgical’s market cap is $9.00.
When is Minerva Surgical’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Minerva Surgical’s earnings last quarter?
Currently, no data Available
Is Minerva Surgical overvalued?
According to Wall Street analysts Minerva Surgical’s price is currently Overvalued.
Does Minerva Surgical pay dividends?
Minerva Surgical does not currently pay dividends.
What is Minerva Surgical’s EPS estimate?
Minerva Surgical’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Minerva Surgical have?
Minerva Surgical has 8,878,582 shares outstanding.
What happened to Minerva Surgical’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Minerva Surgical?
Currently, no hedge funds are holding shares in UTRS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Minerva Surgical
Minerva Surgical, Inc. functions as a commercial-stage medical technology enterprise, specializing in the creation, production, and distribution of innovative, minimally invasive solutions tailored to address the uterine healthcare needs of women throughout the United States. Their suite of offerings features advanced endometrial ablation systems, including the Minerva ES and Genesys HTA. They also provide the Symphion Tissue Removal System, a sophisticated, minimally invasive device for uterine tissue removal that uniquely integrates bladeless tissue resection, coagulation capabilities, continuous visualization during procedures, and precise intrauterine pressure monitoring. Additionally, the Resectr Tissue Resection Device is a handheld surgical tool engineered for the hysteroscopic removal and diagnostic evaluation of endometrial polyps. These specialized instruments are utilized by obstetrician-gynecologists across a variety of clinical settings, such as hospitals, outpatient ambulatory surgical centers, and private physician practices. The company was founded in 2008 and is headquartered in Santa Clara, California.